The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease

Current Drug Targets

Volumn 13, Issue 10, 2012, Pages 1273-1279

  Fiorino, Gionata ^a   Cesarini, Monica ^b   Malesci, Alberto ^a,c   Danese, Silvio ^a   Sorrentino, Dario ^d,e  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF UDINE   (Italy)

Author keywords

Crohn's disease; Fibrosis; Inflammation; Inflammatory bowel disease; Intestinalstrictures; Magnetic resonance imaging

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

CAPILLARY PERMEABILITY; COLITIS; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; HUMAN; INTESTINAL FIBROSIS; INTESTINE WALL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; REVIEW; SCORING SYSTEM; ULTRASOUND; VASCULARIZATION;

CROHN DISEASE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 84866534711     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/138945012802429651     Document Type: Review

References (60)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369(9573): 1641-57.
2. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002; 347(6): 417-29.
3. Peyrin-Biroulet L, Cieza A, Sandborn WJ, et al. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health. Gut 2012; 61(2): 241-7.
4. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8(4): 244-50.
5. Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in population-based cohorts. Am J Gastroenterol 2010; 105(2): 289-97.
6. Sorrentino D. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far? Digestion 2008; 77(1): 38-47.
7. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122(2): 512-30.
8. Cellier C, Sahmoud T, Froguel E, et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut 1994; 35(2): 231-5.
9. Singleton JW. Clinical activity assessment in inflammatory bowel disease. Dig Dis Sci 1987; 32(12 Suppl): 42S-45S
10. Flynn A, Kane S. Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us? Curr Opin Gastroenterol 2011; 27(4): 342-5.
11. Benevento G, Avellini C, Terrosu G, Geraci M, Lodolo I, Sorrentino D. Diagnosis and assessment of Crohn's disease: the present and the future. Expert Rev Gastroenterol Hepatol 2010; 4(6): 757-66.
12. Szabò H, Fiorino G, Spinelli A, et al. Review article: anti-fibrotic agents for the treatment of Crohn's disease-lessons learnt from other diseases. Aliment Pharmacol Ther 2010; 31(2): 189-201.
13. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18(7): 816-27.
14. Sabate JM, Ameziane N, Lamoril J, et al. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease. Eur J Gastroenterol Hepatol 2008; 20(8): 748-55
15. Spinelli A, Correale C, Szabo H, Montorsi M. Intestinal fibrosis in Crohn's disease: medical treatment or surgery? Curr Drug Targets 2010; 11(2): 242-8
16. Patak MA, Mortele KJ, Ros PR. Multidetector row CT of the small bowel. Radiol Clin North Am 2005; 43(6): 1063-77
17. Nolan DJ, Gourtsoyiannis NC. Crohn's disease of the small intestine: a review of the radiological appearances in 100 consecutive patients examined by a barium infusion technique. Clin Radiol 1980; 31(5): 597-603
18. Cirillo LC, Camera L, Della Noce M, Castiglione F, Mazzacca G, Salvatore M. Accuracy of enteroclysis in Crohn's disease of the small bowel: a retrospective study. Eur Radiol 2000; 10(12): 1894-8.
19. Van Assche G, Dignass A, Panes J, et al. The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis 2010; 4(1): 7-27.
20. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008; 5(2): 153-64.
21. Pariente B, Peyrin-Biroulet L, Cohen L, Zagdanski AM, Colombel JF. Gastroenterology review and perspective: the role of crosssectional imaging in evaluating bowel damage in crohn disease. AJR Am J Roentgenol 2011; 197(1): 42-9.
22. Schreyer AG, Geissler A, Albrich H, et al. Abdominal MRI after enteroclysis or with oral contrast in patients with suspected or proven Crohn's disease. Clin Gastroenterol Hepatol 2004; 2(6): 491-7.
23. Wold PB, Fletcher JG, Johnson CD, Sandborn WJ. Assessment of small bowel Crohn disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy--feasibility study. Radiology 2003; 229(1): 275-81.
24. Rieber A, Wruk D, Potthast S, et al. Diagnostic imaging in Crohn's disease: comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000; 15(3): 176-81.
25. Madsen SM, Thomsen HS, Schlichting P, Dorph S, Munkholm P. Evaluation of treatment response in active Crohn's disease by low field magnetic resonance imaging. Abdom Imaging 1999; 24(3): 232-9.
26. Rimola J, Ordás I, Rodriguez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011; 17(8): 1759-68.
27. Ordás I, Rimola J, Ripolles T, et al. Accuracy of MRI to assess therapeutic responses and mucosal healing in Crohn's disease. Gastroenterology 2011; 140(5 (Suppl 1): S-73.
28. Herrmann KA, Michaely HJ, Zech CJ, Seiderer J, Reiser MF, Schoenberg SO. Internal fistulas in Crohn disease: magnetic resonance enteroclysis. Abdom Imaging 2006; 31(6): 675-87.
29. Rimola J, Rodriguez S, García-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009; 58 (8): 1113-20
30. Leyendecker JR, Bloomfeld RS, DiSantis DJ, Waters GS, Mott R, Bechtold RE. MR enterography in the management of patients with Crohn disease. Radiographics 2009; 29(6): 1827-46.
31. Gourtsoyiannis NC, Papanikolaou N, Karantanas A. Magnetic resonance imaging evaluation of small intestinal Crohn's disease. Best Pract Res Clin Gastroenterol 2006; 20(1): 137-56.
32. MacKenzie JD, Vasanawala SS. Advances in pediatric MR imaging. Magn Reson Imaging Clin N Am 2008; 16(3): 385-402.
33. Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007; 17(9): 2294-301.
34. Rimola J, Rodriguez S, Garcia-Bosch O, et al. Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease. Radiographics 2009; 29(3): 701-19.
35. Fidler J. MR imaging of the small bowel. Radiol Clin North Am 2007; 45(2): 317-31.
36. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: metaanalysis of prospective studies. Radiology 2008; 247(1): 64-79.
37. Messaris E, Chandolias N, Grand D, Pricolo V. Role of magnetic resonance enterography in the management of Crohn disease. Arch Surg 2010; 145(5): 471-5.
38. Sinha R, Verma R, Verma S, Rajesh A. MR enterography of Crohn disease: part 1, rationale, technique, and pitfalls. AJR Am J Roentgenol 2011; 197(1): 76-9.
39. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359(9317): 1541-9.
40. Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006; 130(7): 2060-73.
41. Masselli G, Vecchioli A, Gualdi GF. Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom Imaging 2006; 31(4): 400-9.
42. Gee MS, Nimkin K, Hsu M, et al. Prospective evaluation of MR enterography as the primary imaging modality for pediatric Crohn disease assessment. AJR Am J Roentgenol 2011; 197(1): 224-31.
43. Giusti S, Faggioni L, Neri E, et al. Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease. Abdom Imaging 2010; 35(6): 646-53.
44. Lawrance IC, Welman CJ, Shipman P, Murray K. Correlation of MRI-determined small bowel Crohn's disease categories with medical response and surgical pathology. World J Gastroenterol 2009; 15(27): 3367-75.
45. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009; 252(3): 712-20.
46. Taylor SA, Punwani S, Rodriguez-Justo M, et al. Mural Crohn disease: correlation of dynamic contrast-enhanced MR imaging findings with angiogenesis and inflammation at histologic examination--pilot study. Radiology 2009; 251(2): 369-79.
47. Ziech ML, Bipat S, Roelofs JJ, et al. Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn's disease patients. Eur J Radiol 2011; 80(3): e299-305.
48. Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008; 33(4): 417-24.
49. Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000; 25(3): 219-28.
50. Zappa M, Stefanescu C, Cazals-Hatem D, et al. Which magnetic resonance imaging findings accurately evaluate inflammation in small bowel Crohn's disease? A retrospective comparison with surgical pathologic analysis. Inflamm Bowel Dis 2011; 17(4): 984-93.
51. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005; 3(12): 1221-8.
52. Miao YM, Koh DM, Amin Z, et al. Ultrasound and magnetic resonance imaging assessmentof active bowel segments in Crohn's disease. Clin Radiol 2002; 57(10): 913-8.
53. Fornasa F, Benassuti C, Benazzato L. Role of Magnetic Resonance Enterography in Differentiating between Fibrotic and Active Inflammatory Small Bowel Stenosis in Patients with Crohn's Disease. J Clin Imaging Sci 2011; 1: 35.
54. Angerson WJ, Allison MC, Baxter JN, Russell RI. Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993; 34(11): 1531-4.
55. Hulten L, Lindhagen J, Lundgren O, Fasth S, Ahrén C. Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology 1977; 72(3): 388-96.
56. Tateishi S, Arima S, Futami K. Assessment of blood flow in the small intestine by laser Doppler flowmetry: comparison of healthy small intestine and small intestine in Crohn's disease. J Gastroenterol 1997; 32(4): 457-63.
57. Walker-Samuel S, Leach MO, Collins DJ. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 2006; 51(14): 3593-602.
58. Sostegni R, Daperno M, Scaglione N, Lavagna A, Rocca R, Pera A. Review article: Crohn's disease: monitoring disease activity. Aliment Pharmacol Ther 2003; 17(Suppl. 2): 11-17.
59. Lenze F, Wessling J, Bremer J, et al. Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: Prospective comparison of (18) F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation. Inflamm Bowel Dis 2012. doi: 10.1002/ibd.22930. [Epub ahead of print].
60. Adler J, Swanson SD, Schmiedlin-Ren P, et al. Magnetization transfer helps detect intestinal fibrosis in an animal model of Crohn disease. Radiology 2011; 259(1): 127-35.